Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anti-PD-L1 inhibitor durvalumab in bladder cancer.
Brower V. Brower V. Lancet Oncol. 2016 Jul;17(7):e275. doi: 10.1016/S1470-2045(16)30242-X. Epub 2016 Jun 16. Lancet Oncol. 2016. PMID: 27321156 No abstract available.
Hyperprogressive disease with anti-PD-1 and anti-PD-L1.
Brower V. Brower V. Lancet Oncol. 2016 Dec;17(12):e527. doi: 10.1016/S1470-2045(16)30590-3. Epub 2016 Nov 18. Lancet Oncol. 2016. PMID: 27866860 No abstract available.
Anti-PD-L1 antibody active in metastatic bladder cancer.
Brower V. Brower V. Lancet Oncol. 2015 Jan;16(1):e11. doi: 10.1016/S1470-2045(14)71167-2. Epub 2014 Dec 5. Lancet Oncol. 2015. PMID: 25638546 No abstract available.
Dual HER2 inhibition and paclitaxel in metastatic breast cancer.
Brower V. Brower V. Lancet Oncol. 2015 Feb;16(2):e57. doi: 10.1016/S1470-2045(14)71201-X. Epub 2015 Jan 9. Lancet Oncol. 2015. PMID: 25577955 No abstract available.
Adjuvant trastuzumab improves survival in early breast cancer.
Brower V. Brower V. Lancet Oncol. 2014 Dec;15(13):e589. doi: 10.1016/S1470-2045(14)71110-6. Epub 2014 Oct 31. Lancet Oncol. 2014. PMID: 25499286 No abstract available.
Predicting response to cisplatin in NSCLC.
Brower V. Brower V. Lancet Oncol. 2007 Aug;8(8):674. doi: 10.1016/s1470-2045(07)70226-7. Lancet Oncol. 2007. PMID: 17726780 No abstract available.
Atezolizumab in advanced non-small-cell lung cancer.
Brower V. Brower V. Lancet Oncol. 2017 Aug;18(8):e434. doi: 10.1016/S1470-2045(17)30504-1. Epub 2017 Jun 22. Lancet Oncol. 2017. PMID: 28648559 No abstract available.
Letrozole not superior to anastrozole for early breast cancer.
Brower V. Brower V. Lancet Oncol. 2017 Mar;18(3):e138. doi: 10.1016/S1470-2045(17)30081-5. Epub 2017 Feb 3. Lancet Oncol. 2017. PMID: 28163005 No abstract available.
Bortezomib improves survival in rare myeloma.
Brower V. Brower V. Lancet Oncol. 2016 Jun;17(6):e227. doi: 10.1016/S1470-2045(16)30129-2. Epub 2016 May 6. Lancet Oncol. 2016. PMID: 27160479 No abstract available.
Nodal radiation in breast cancer does not improve survival.
Brower V. Brower V. Lancet Oncol. 2015 Sep;16(9):e430. doi: 10.1016/S1470-2045(15)00203-X. Epub 2015 Jul 30. Lancet Oncol. 2015. PMID: 26234171 No abstract available.
238 results
Jump to page
Feedback